RE: Innova £1.2 billion contract win10 Apr 2021 19:25
questions that remain unanswered:
why was the sample size for testing only 70 or was it 75 when lab results were showing such a promising ‘gold standard’ superior product ?
why has it, given such a small sample size, taken a year to collate/publish results?
Why has it taken so long for Porton Down to complete assessments of any of the Uk Tests.
why are Uk tests, showing to be at least better than the Innova ones, not being given emergency approval based on that fact whilst ongoing regulatory bodies make their final findings/certifications.
why have all the uk based/produced alternatives been held up by the regulatory approval process ( bar Novacyt who were originally passed over completely and only taken on board after WHO rating, certification and approval. and look where they are now and how they are being treated) when we have an undeniable urgent need for a better test.
Why are emergency procurement procedures a year into a global pandemic still being given as the excuse and avenue for continued ‘innova’ crap test purchasing despite their almost universal slating as utterly substandard?
Who are Tried and Tested a company recently set up and run from a three bedroom house in Northamptonshire?
Why are Tried and Tested being given preferential treatment in the procurement of (Innova) tests?
i’m sure there are many more questions that investors would also like answering. my faith is dwindling, not in the product,i see a good strong future for Avacta. However, given how things have gone for Novacyt last week, and given the shambles that is the UK govt and its apparent strangle hold on the infrastructure that is supposed to facilitate these things i’m beginnig to get a bad taste in my mouth. and as a share holder of all the uk companies in the Covid testing/treatment sphere i’m seriously considering reducing my exposure across the board.